TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats
International Immunopharmacology · 2026-08 · 183 · 116884
DOI: 10.1016/j.intimp.2026.116884 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-08. Verfasst von Antonio González-Ruiz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid,…. Hauptthemen laut MEDLINE: Cisplatin, Toll-Like Receptor 4, Antineoplastic Agents, Cardiotoxicity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: H2020 European Research Council, Community of Madrid Department of Education Science and Universities, State Agency of Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid, Spain; High Performance Research Group in Experimental Pharmacology (…
- Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), c/ Juan de la Cierva 3, 28006 Madrid, Spain.
- Instituto de Química Médica (IQM), Consejo Superior de Investigaciones Científicas (CSIC), c/ Juan de la Cierva 3, 28006 Madrid, Spain; High Performance Research Group in Experimental Pharmacology (PHARMAKOM-URJC), Univ…
- Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Avda. Atenas s/n 28922 Alcorcón, Madrid, Spain; Unidad Asociada I+D+i al Instituto de Química Médica (IQM), Co…
Förderung
- H2020 European Research Council
- Community of Madrid Department of Education Science and Universities
- State Agency of Research
- European Social Fund Plus
- Consejo Superior de Investigaciones Científicas
- Health Sciences, University of Arizona
- Comunidad de Madrid
- Ministerio de Ciencia e Innovación
Zitieren
APA
González-Ruiz, A., Flaj, S., Fernández-Cabello, V., Quesada, E., López-Miranda, V., & Herradón, E. (2026). TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats. International Immunopharmacology, 183, 116884. https://doi.org/10.1016/j.intimp.2026.116884
Vancouver
González-Ruiz A, Flaj S, Fernández-Cabello V, Quesada E, López-Miranda V, Herradón E. TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats. International Immunopharmacology. 2026;183:116884. doi:10.1016/j.intimp.2026.116884
BibTeX
@article{GonzlezRuiz2026,
author = {González-Ruiz, Antonio and Flaj, Silvia and Fernández-Cabello, Víctor and Quesada, Ernesto and López-Miranda, Visitación and Herradón, Esperanza},
title = {TLR4 receptor blockade diminishes cardiac and renal toxicity induced by cisplatin treatment in rats},
journal = {International Immunopharmacology},
year = {2026},
volume = {183},
pages = {116884},
doi = {10.1016/j.intimp.2026.116884}
}
EUVIMED